184 related articles for article (PubMed ID: 26413163)
1. Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis.
Brandt EJ; Regnier SM; Leung EK; Chou SH; Baron BW; Te HS; Davidson MH; Sargis RM
Clin Lipidol; 2015 Aug; 10(4):305-312. PubMed ID: 26413163
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolemia Due to Lipoprotein X: Case Report and Thematic Review.
Kattah L; Gómez A; Gutiérrez S; Puerto K; Moreno-Pallares ED; Jaramillo A; Mendivil CO
Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419878687. PubMed ID: 31632171
[TBL] [Abstract][Full Text] [Related]
3. Severe hypercholesterolemia and liver disease in a 3-year old.
Patel AM; Brautbar A; Desai NK; Wilson DP
J Clin Lipidol; 2016; 10(3):650-3. PubMed ID: 27206954
[TBL] [Abstract][Full Text] [Related]
4. Monocyte phenotyping and management of lipoprotein X syndrome.
Lian Z; Saeed A; Peng X; Perrard XD; Jia X; Hussain A; Ballantyne CM; Wu H
J Clin Lipidol; 2020; 14(6):850-858. PubMed ID: 33011137
[TBL] [Abstract][Full Text] [Related]
5. Severe Hypercholesterolemia Mediated by Lipoprotein X in an Immunosuppressed Patient: A Case Report.
Sequeira C; Coelho M; Costa Santos I; Ramos Lopes S; Mangualde J; Oliveira AP
GE Port J Gastroenterol; 2023 Oct; 30(5):398-402. PubMed ID: 37868638
[TBL] [Abstract][Full Text] [Related]
6. Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse.
Bravo I; Amigo L; Cohen DE; Nervi F; Rigotti A; Francone O; Zanlungo S
Biochim Biophys Acta; 2007 Jun; 1770(6):979-88. PubMed ID: 17399905
[TBL] [Abstract][Full Text] [Related]
7. Rapid normalization of severe hypercholesterolemia mediated by lipoprotein X after liver transplantation in a patient with cholestasis - a case report.
Jankowski K; Wyzgał A; Wierzbicka A; Tronina O; Durlik M; Pruszczyk P
Acta Biochim Pol; 2015; 62(3):621-3. PubMed ID: 26317127
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-X fifty years after its original discovery.
Fellin R; Manzato E
Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):4-8. PubMed ID: 30503707
[TBL] [Abstract][Full Text] [Related]
9. Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis.
Colantuono R; Pavanello C; Pietrobattista A; Turri M; Francalanci P; Spada M; Vajro P; Calabresi L; Mandato C
Front Pediatr; 2022; 10():969081. PubMed ID: 35989999
[TBL] [Abstract][Full Text] [Related]
10. A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X.
Neufeld EB; Freeman LA; Durbhakula V; Sampson ML; Shamburek RD; Karathanasis SK; Remaley AT
Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009874
[TBL] [Abstract][Full Text] [Related]
11. Hypercholesterolemia After COVID-19: Time to Include Lipoprotein X Among the Differential Diagnoses.
Girard J; Wagner C; Ravi S; Agarwal M; Bril F
AACE Clin Case Rep; 2023; 9(2):35-38. PubMed ID: 36643829
[TBL] [Abstract][Full Text] [Related]
12. Plasma antioxidant levels in chronic cholestatic liver diseases.
Floreani A; Baragiotta A; Martines D; Naccarato R; D'odorico A
Aliment Pharmacol Ther; 2000 Mar; 14(3):353-8. PubMed ID: 10735930
[TBL] [Abstract][Full Text] [Related]
13. Lipids and lipid-activated vitamins in chronic cholestatic diseases.
Kowdley KV
Clin Liver Dis; 1998 May; 2(2):373-89, x. PubMed ID: 15560038
[TBL] [Abstract][Full Text] [Related]
14. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
Buckley SE; DiPalma JA
Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
[TBL] [Abstract][Full Text] [Related]
15. Extreme hypercholesterolemia presenting with pseudohyponatremia - a case report and review of the literature.
Hussain I; Ahmad Z; Garg A
J Clin Lipidol; 2015; 9(2):260-4. PubMed ID: 25911084
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
[TBL] [Abstract][Full Text] [Related]
17. Resolving hyperlipidemia after liver transplantation in a patient with primary sclerosing cholangitis.
Gandelman G; Aronow WS; Weiss MB
Am J Ther; 2006; 13(2):171-4. PubMed ID: 16645435
[TBL] [Abstract][Full Text] [Related]
18. Severe hypercholesterolemia mediated by lipoprotein X in a patient with cholestasis.
Phatlhane DV; Zemlin AE
Ann Hepatol; 2015; 14(6):924-8. PubMed ID: 26436366
[TBL] [Abstract][Full Text] [Related]
19. A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.
Zhu X; Herzenberg AM; Eskandarian M; Maguire GF; Scholey JW; Connelly PW; Ng DS
Am J Pathol; 2004 Oct; 165(4):1269-78. PubMed ID: 15466392
[TBL] [Abstract][Full Text] [Related]
20. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
Aljenedil S; Ruel I; Watters K; Genest J
J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
